10.1002/chem.202101052
Chemistry - A European Journal
FULL PAPER
[1]
[2]
K. Kitamura, Y. Ando, T. Matsumoto, K. Suzuki, Chem.
Rev. 2018, 118, 1495-1598.
a) E. De Clercq, J. Med. Chem. 2016, 59, 2301-2311; b)
D. S. Hsia, O. Grove, W. T. Cefalu, Curr. Opin. Endocrinol.
Diabetes Obes. 2017, 24, 73-79.
S. E. Denmark, C. S. Regens, T. Kobayashi, J. Am.
Chem. Soc. 2007, 129, 2774-2776.
K. Parkan, R. Pohl, M. Kotora, Chem.-Eur. J. 2014, 20,
4414-4419.
strategy for the synthesis of pharmaceutically important
dapagliflozin in the overall yield of 79%. Next, we have verified
that our stereoselective procedure is also useful for the
preparation of dapagliflozin analogues with 2-deoxy-β-D-gluco
and α-D-gluco configuration in good overall yields (84% and 56%)
from 1-diisopropylsilyl-D-glucal 4.
[3]
[4]
[5]
A. K. Ghosh, A. M. Veitschegger, S. Nie, N. Relitti, A. J.
MacRae, M. S. Jurica, J. Org. Chem. 2018, 83, 5187-
5198.
Experimental Section
[6]
[7]
T. C. Ho, H. Kamimura, K. Ohmori, K. Suzuki, Org. Lett.
2016, 18, 4488-4490.
General procedure A for Hiyama cross-coupling reaction
A. R. Aguillón, A. Mascarello, N. D. Segretti, H. F. Z. de
Azevedo, C. R. W. Guimaraes, L. S. M. Miranda, R. O. M.
A. de Souza, Org. Process Res. Dev. 2018, 22, 467-488.
a) K. W. Wellington, S. A. Benner, Nucleosides
Nucleotides Nucleic Acids 2006, 25, 1309-1333; b) F.
Otte, B. Schmidt, J. Org. Chem. 2019, 84, 14816-14829.
a) J. Choutka, R. Pohl, K. Parkan, ACS Omega 2018, 3,
7875-7887; b) E. Dubois, J.-M. Beau, Carbohydr. Res.
1992, 228, 103-120.
a) L. Gong, H.-B. Sun, L.-F. Deng, X. Zhang, J. Liu, S.
Yang, D. Niu, J. Am. Chem. Soc. 2019, 141, 7680-7686;
b) R. W. Friesen, R. W. Loo, J. Org. Chem. 1991, 56,
4821-4823.
TMAF•4H2O (2.2 equiv.) was added to
a 0.24M solution of 1-
diisopropylsilyl-D-glucal (1.2 equiv.) in anhydrous DMF at room
4
[8]
temperature under an argon atmosphere. After 15 min, [PdCl(allyl)]2
catalyst (0.025 equiv.) and the corresponding aryl halide (1 equiv.) were
subsequently added, and the reaction mixture was stirred for 16 h. After
consumption of the starting material, the reaction mixture was
concentrated in vacuo and the resulting residue was purified by column
chromatography on silica to afford the desired product 5a-n. In some
cases, the obtained compounds were additionally purified by prep-HPLC
on Phenomenex (Luna C18) column.
[9]
[10]
[11]
[12]
[13]
M. A. Tius, X. Q. Gu, J. Gomez-Galeno, J. Am. Chem.
Soc. 1990, 112, 8188-8189.
S. E. Denmark, T. Kobayashi, C. S. Regens, Tetrahedron
2010, 66, 4745-4759.
F. Zhu, J. Rodriguez, T. Yang, I. Kevlishvili, E. Miller, D.
Yi, S. O’Neill, M. J. Rourke, P. Liu, M. A. Walczak, J. Am.
Chem. Soc. 2017, 139, 17908-17922.
K. H. Shaughnessy, Molecules 2015, 20, 9419-9454.
a) B. Oroszova, J. Choutka, R. Pohl, K. Parkan, Chem.-
Eur. J. 2015, 21, 7043-7047; b) I. Snajdr, K. Parkan, F.
Hessler, M. Kotora, Beilstein J. Org. Chem. 2015, 11,
1392-1397.
a) F. Foubelo, C. Nájera, M. Yus, Chem. Rec. 2016, 16,
2521-2533; b) S. E. Denmark, L. Neuville, Org. Lett. 2000,
2, 3221-3224.
D. J. Sam, H. E. Simmons, J. Am. Chem. Soc. 1974, 96,
2252-2253.
I. Fleming, J. A. Langley, J. Chem. Soc.-Perkin Trans. 1
1981, 1421-1423.
S. E. Denmark, D. Wehrli, J. Y. Choi, Org. Lett. 2000, 2,
2491-2494.
K. Hosoi, K. Nozaki, T. Hiyama, Proc. Jpn. Acad. Ser. B-
Phys. Biol.Sci. 2002, 78, 154-160.
K. Itami, T. Nokami, Y. Ishimura, K. Mitsudo, T. Kamei, J.-
i. Yoshida, J. Am. Chem. Soc. 2001, 123, 11577-11585.
B. Oroszova, J. Choutka, R. Pohl, K. Parkan, Chem.-Eur.
J. 2015, 21, 7043-7047.
S. Hu, W. Sun, Y. Wang, H. Yan, Med. Chem. Res. 2019,
28, 465-472.
D. C. Koester, M. Leibeling, R. Neufeld, D. B. Werz, Org.
Lett. 2010, 12, 3934-3937.
General procedure B for hydroboration-oxidation
To a 0.025M solution of corresponding coupling product 5a-d and 5n (1
equiv.) in anhydrous THF, BH3•THF complex solution (1.0 M in THF, 10
equiv.) was added dropwise at 0°C. The resulting mixture was stirred for
10 min at this temperature and then warmed to room temperature and
stirred for next 16 h (overnight). Then the mixture was cooled to 0 °C again
and 30% solution of H2O2 and 30% solution of NaOH (2 mL, 1:1) were
[14]
[15]
added simultaneously dropwise. After
a slow transition to room
temperature (approx. 20 min), the reaction mixture was filtered through
Celite and concentrated in vacuo. The residue was purified by column
chromatography on silica to provide the desired aryl β-C-glycoside 7a-d
and 7n. In some cases, the obtained compounds were additionally purified
prep-HPLC on Phenomenex (Luna C18) column.
[16]
[17]
[18]
[19]
[20]
[21]
[22]
[23]
[24]
[25]
General procedure C for hydrogenation
To a 0.016M solution of corresponding coupling products 5b, 5h, and 5n
(1 equiv.) in ethanol PtO2 (0.05 mmol, 0.5 equiv.) was added. The resulting
mixture was stirred for 40 min under a hydrogen atmosphere for 2 h. The
mixture was filtered through Celite and concentrated in vacuo. The
residue was purified by column chromatography on silica to provide the
desired aryl 2-deoxy-β-C-glycosides 8b, 8h, and 8n.
Acknowledgements
H. Mikula, D. Svatunek, D. Lumpi, F. Glöcklhofer, C.
Hametner, J. Fröhlich, Org. Process Res. Dev. 2013, 17,
313-316.
This work was financially supported from specific university
research (grant No. A1_FPBT_2021_002). We also appreciate
the support from Gilead Sciences, Inc., provided under the
program ‘Molecules for Life’ at the Gilead Sciences & IOCB
Prague Research Centre.
Conflict of interest
The authors declare no conflict of interest.
Keywords: protecting-group-free • Hiyama reaction • cross-
coupling • aryl C-glycosides • dapagliflozin
5
This article is protected by copyright. All rights reserved.